GRFS Grifols SA ADRs

Grifols SA is a pharmaceutical company. It primarily collects the liquid portion of human blood called plasma and then manufactures and sells plasma-derived products globally. It also operates diagnostics, hospital supplies, and raw materials businesses. This is an ADR of a company whose stock trades outside of the U.S. as the symbol SM:GRF.P .

$13.79  -0.44 (-3.06%)
As of 10/18/2021 15:59:38 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  ADRs
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—General
Index country:  Spain
Country of incorporation:  Spain
IPO date:  06/02/2011
Outstanding shares:  261,425,000
Average volume:  692,937
Market cap:   $3,699,163,750
Current dividend yield:  3.23%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
CUSIP:    398438408
ISIN:        US3984384087
Sedol:      B8K7T65
Valuation   (See tab for details)
PE ratio:   25.30
PB ratio:   3.76
PS ratio:   0.61
Return on equity:   9.62%
Net income %:   12.83%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy